Michael Robert Martin is Chief Business Officer of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 259,162 shares of AUPH, which is worth approximately $2.3 Million. The most recent transaction as insider was on Jun 22, 2021, when has been sold 5,000 shares (Common Stock) at a price of $13.76 per share, resulting in proceeds of $68,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 259K
0% 3M change
0% 12M change
Total Value Held $2.3 Million

Michael Robert Martin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 22 2021
SELL
Open market or private sale
$68,800 $13.76 p/Share
5,000 Reduced 2.25%
216,861 Common Stock
May 11 2021
BUY
Exercise of conversion of derivative security
$60,400 $3.02 p/Share
20,000 Added 8.27%
221,861 Common Stock
MRM

Michael Robert Martin

Chief Business Officer
Victoria, A1

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Track Activities on AUPH